Receptor activator of nuclear factor kappa B ligand (RANKL): another link between breast and bone.
about
Disabling of receptor activator of nuclear factor-kappaB (RANK) receptor complex by novel osteoprotegerin-like peptidomimetics restores bone loss in vivoCoordinated increased expression of Cyclooxygenase2 and nuclear factor κB is a steady feature of urinary bladder carcinogenesisWITHDRAWN: Cardamonin Inhibits Osteoclastogenesis Induced by Tumor Cells Through Interruption of the Signaling Pathway Activated by Receptor Activator of NF-κB Ligand.RANKL signaling and osteoclastogenesis is negatively regulated by cardamoninExpression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumours.Salinosporamide A (NPI-0052) potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through down-modulation of NF-kappaB regulated gene products.Role of interleukin-7 in bone and T-cell homeostasis.Osteoporosis associated with antipsychotic treatment in schizophreniaAntipsychotics and hyperprolactinaemia: mechanisms, consequences and management.RANK expression on breast cancer cells promotes skeletal metastasis.Oct-1 counteracts autoinhibition of Runx2 DNA binding to form a novel Runx2/Oct-1 complex on the promoter of the mammary gland-specific gene beta-caseinInverse expression of estrogen receptor-beta and nuclear factor-kappaB in urinary bladder carcinogenesis.Role of Runx2 in IGF-1Rβ/Akt- and AMPK/Erk-dependent growth, survival and sensitivity towards metformin in breast cancer bone metastasis.
P2860
Q28191731-D7AFDB32-D4CA-4319-9032-4DB9786AB5CFQ34106055-4BF48DE3-25CC-439A-9B61-8E810272A741Q34241611-3996C8DE-CB64-4311-B16D-87C0D4BD0F1EQ34731280-1C32DB04-6BE5-4929-9155-350D38ED6667Q35769514-FF950AD2-D3D7-4652-BB5C-84904E885779Q36007617-B29F2AE4-8197-48AB-A88F-608A76FD0525Q36324952-1B16E5C6-A77A-4E5F-8D34-F798908A5F91Q36838238-F97FACA4-7401-4B93-8560-24224ED42A6BQ37747570-C82DC7D0-54F5-445D-8BBA-C0EA839899EAQ39055979-EF9F6B28-3371-49C6-825B-F07CB5C73BC9Q42709917-2F660B5F-D3FC-48CF-947B-7048DADE7602Q44249011-E269B7D4-A5E2-4F64-A21A-448C41225815Q53197894-6E7CF7FF-9B93-4CA2-BBF0-1001B4A26C28
P2860
Receptor activator of nuclear factor kappa B ligand (RANKL): another link between breast and bone.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Receptor activator of nuclear ...... link between breast and bone.
@ast
Receptor activator of nuclear ...... link between breast and bone.
@en
Receptor activator of nuclear factor kappa B ligand
@nl
type
label
Receptor activator of nuclear ...... link between breast and bone.
@ast
Receptor activator of nuclear ...... link between breast and bone.
@en
Receptor activator of nuclear factor kappa B ligand
@nl
prefLabel
Receptor activator of nuclear ...... link between breast and bone.
@ast
Receptor activator of nuclear ...... link between breast and bone.
@en
Receptor activator of nuclear factor kappa B ligand
@nl
P1476
Receptor activator of nuclear ...... link between breast and bone.
@en
P2093
Gillespie MT
P356
10.1016/S1043-2760(00)00351-9
P577
2001-01-01T00:00:00Z